-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexaria Bioscience Announces Australian Tax Office Pays AU$3.667M In Tax Rebate To Co.

Benzinga·09/01/2026 13:16:36
Listen to the news

Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that it has received a cash rebate of AUD$3,666,611.98 from the Australian Tax Office. The funds were deposited into the bank account of Lexaria's wholly-owned Australian subsidiary company, Lexaria (AU) Pty Ltd.